The mission of NNECOS is to promote the highest quality care for patients with cancer and blood disorders in our region through professional networking, education, and scientific research, as well as patient advocacy and public policy. 

Memorial Day


Wishing you time for reflection and a safe Memorial Day Weekend.



NNECOS Research Funding Program

Since the program’s inception in 2008, NNECOS has awarded nearly $180,000 to support research projects in Northern New England.

Congratulations, Dr. Ahmed

Congratulations, Dr. Ahmed!

NNECOS is delighted to announce the funding of a fascinating pilot study being conducted by Dr. Shahid Ahmed of the University of Vermont Medical Center. Dr. Ahmed will embark on a pilot correlative study of how bacteria influence the formation of an immune-escaped bladder cancer. Congratulations, Dr. Ahmed!

Research Funding Application Deadline is July 31st

Do you have an idea for an investigative project of value to the Northern New England community of cancer care providers? Submit your proposal by July 31st. Up to $20,000 is available for research grant funding. Learn more at

NNECOS Student-Led Project Funding

NNECOS is committed to supporting students in their exploration of projects of value to the community of cancer-care providers and cancer survivors through the provision of student-led project grants. Since the program’s inception, NNECOS has awarded more than $25,000 through this program.

Congratulations, Stephanie Kim

Community Rowing Program During Cancer Treatment Study

Congratulations to Stephanie Kim, a medical student at Geisel School of Medicine at Dartmouth College, who was recently awarded a NNECOS Student Grant supporting her project, “Investigation of the increased compliance to exercise with a community rowing program during cancer treatment.” Stephanie will conduct a qualitative, descriptive study investigating how a community rowing program can help increase exercise adherence during cancer recovery. Read more at


Rolling Application Deadline for Student-Led Project Funding

If you, or a student you know, has an interesting project idea, we encourage submission. All members of the interdisciplinary team are invited to apply. Applications are reviewed on a rolling basis, with up to $7,500 in funding available annually.

NNECOS Strategic Plan Update

In May, the board continued its steadfast work on our strategic priorities with significant philanthropic and research funds awarded. Task force members continued to evaluate and improve the organization's infrastructure to ensure meaningful ways for the Northern New England oncology community to engage with colleagues in society work throughout the year. Having a robust pool of involved professionals to participate as NNECOS leaders will be essential to the continued pursuit of our mission to promote the highest quality care for patients with cancer and blood disorders in our region.

A key area of focus in our strategic plan implementation involves connecting with the NNECOS community to discuss how NNECOS can work for YOU and your patients. While we await the opportunity to meet in person at our annual meeting in Burlington Vermont this October, NNECOS has begun hosting virtual informational salons to conduct these important conversations.

  • What challenges or struggles are you facing?
  • How can NNECOS help?
  • What programs or services do you most value?

If you would be interested in participating in an upcoming informational salon, please contact Lori Aubrey at for more information.

The risk of not getting involved is that the most expert voices will not be heard. And then, the policies we have to live with won’t reflect what we know is best for our patients. Clifford A. Hudis, ASCO Chief Executive Officer.

"The risk of not getting involved is that the most expert voices will not be heard. And then, the policies we have to live with won’t reflect what we know is best for our patients." 

Clifford A. Hudis, MD, FACP, FASCO

ASCO Chief Executive Officer

Our voices are important in advocating for our patients. Visit to learn more about current federal and local legislative issues impacting cancer care and ways to lend your voice to ongoing efforts.

NNECOS Classifieds

NNECOS offers its member practices an opportunity to request advertisement on our website via the NNECOS Classifieds page. If your practice is looking for a new team member, or if you’re interested in exploring new career opportunities, we invite you to connect with the NNECOS Classifieds.  

Currently posted listings include:

  • UVM Medical Center is seeking a physician with experience in hematologic malignancies, autologous stem cell transplantation and CAR-T cell therapy
  • Medical Oncologist/Hematologist (Northern New York)
  • Multiple Positions - New England Cancer Specialists Maine & New Hampshire
Cancer Community Support

This month, the Emergency-Need Grant and Grocery/Gas Card Programs continued to reach patients experiencing unprecedented need facing a cancer diagnosis during a global pandemic, awarding an additional $2,500 in grocery/gas cards, and $21,000 in emergency need grants.

We are thrilled to support patients with cancer in partnership with the following centers and foundations:

  • Southwestern Vermont Regional Cancer Center Patient Assistance Fund
  • St. Mary's Regional Medical Center – St. Mary’s Foundation
  • Dartmouth Hitchcock Medical Center Bone Marrow Transplant and CAR T-Cell program Patient Emergency Fund
  • Radiation Center of Greater Nashua Patient Assistance Fund
  • Cancer Resource Center of Western Maine
  • Cancer Patient Support Foundation of Vermont
  • The Center for Cancer Care at Exeter Hospital – Beyond the Rainbow
  • Central Vermont Medical Center


NNECOS Regional Educational Programs

The NNECOS Regional Educational Programs page provides information about educational opportunities that may be of interest to the NNECOS community. Member institutions, corporate member companies and non-profit organizations are eligible to submit requests to share programs on this page. Upcoming events include:

  • June 15 - Discussion on lung cancer screening and the diagnostic & treatment pathway, as well as key aspects of managing metastatic NSCLC
  • June 17 - Discussion on clinical considerations for patients with unresectable stage III non-small cell lung cancer

NNECOS is a member of ASCO’s State Affiliate Council, an advisory group to its Board of Directors. To increase engagement with oncology professionals throughout the country, NNECOS Active Associate, Active Physician, Fellow, and Emeritus members invited to join the State Society Network, a new online community for State Society members. As a member of this community, you can participate in discussions with peers in other states, as well as your own, ask questions, share information, access resource documents, and communicate with the leadership and members of ASCO’s State Affiliate Council.

 Join the State Society Network and begin networking with your peers.


After navigating to the community, please login using your ASCO username and password and select Join Community located in the top righthand corner of your browser. If you do not have an ASCO account, please visit to create a profile.

Please reach out to Lisa-Marie Pratt with any questions.

ASCO in Action

ASCO-ACCC Piloting Test Tools to Diversify Cancer Clinical Trials

In their continued collaboration to increase clinical trial participation among patients from underrepresented racial and ethnic groups, the American Society of Clinical Oncology (ASCO) and Association of Community Cancer Centers (ACCC) announced plans to test a research site assessment tool and implicit bias training program, both of which are designed to address one of the barriers to clinical trial participation: trials not routinely being offered by clinicians to eligible patients.


This initial phase is a pilot project focused on screening and participation outcomes for patients who are Black and/or Hispanic/Latinx. In subsequent efforts, ASCO and ACCC plan to modify the resources to address other underrepresented racial and ethnic groups. Individual research sites located in the United States are invited to apply to participate in the pilot project to test these resources. We are seeking over 40 oncology research sites and locations from a mix of research and practice settings, including small and large research sites, and community- and academic-based oncology programs from diverse geographic regions. Learn more about this initiative through the ASCO-ACCC Collaboration page. Recruitment will remain open through June 11, 2021.

Medicare Pharmacy Benefits Final Rule Addresses Cost Sharing Limits

On April 30, 2021, the Centers for Medicare & Medicaid Services (CMS) released part two of the Notice of Benefit and Payment Parameters for 2022 and Pharmacy Benefit Standards final rule (NBPP). The rule finalizes some of the standards in the proposed rule for states, exchanges, non-federal governmental plans, issuers in the individual and small-group markets (including those that participate in the federally facilitated exchange direct enrollment program), and web brokers. Read more at ASCO in Action.

New ASCO Journal Series Examines Disparities in Cancer Care for Black People in the United States

Black People in the United States A new special series in JCO Oncology Practice, a journal of the American Society of Clinical Oncology (ASCO), explores the causes of disparities in cancer care and outcomes for Black people in the United States and examines potential solutions for addressing health inequities in this population. The “Disparities in Cancer Care for Black People in the United States” special series covers a wide range of relevant topics and presents new data that examine the barriers many Black individuals face in receiving high-quality, equitable cancer care as well as opportunities for clinicians and the U.S. healthcare system to address these barriers. Read more on ASCO in Action.


ACT NOW: Improving Seniors’ Timely Access to Care Act

The Improving Seniors’ Timely Access to Care Act, H.R. 3173, was recently reintroduced by Representatives Suzan DelBene (D-WA-1), Mike Kelly (R-PA-16), Dr. Ami Bera (D-CA-7), and Larry Bucshon (R-IN-08). This legislation aims to streamline prior authorization practices within the Medicare Advantage Program.


Current prior authorization practices create delays in care that can negatively impact patients with cancer and lead to unnecessary disease progression. H.R. 3173 would create an electronic prior authorization process, hold plans accountable for timeliness of determinations, improve transparency within the prior authorization process, and prohibit additional prior authorization for added medically necessary services.


Urge your Representatives to support this legislation by visiting the ACT Network.

CMS Reweights 2020 MIPS Cost Category

The Centers for Medicare & Medicaid Services (CMS) recently announced updates to the

Merit-based Incentive Payment System (MIPS) under the Quality Payment Program (QPP). The agency reweighted the 2020 MIPS cost performance category, opened applications for the 2021 MIPS promoting interoperability performance category hardship and extreme and uncontrollable circumstances exceptions, and released MIPS Cost measure benchmarks. Read more on ASCO in Action.

Recording Available from ASCO's Virtual Roundtable on Equity in Precision Cancer Care

On May 25, 2021, the American Society of Clinical Oncology (ASCO) hosted a virtual roundtable, entitled, 'From Diagnosis to Treatment: Ensuring Equity in Precision Cancer Care," which focused on achieving equity in precision cancer care. Moderated by ASCO President Lori J. Pierce, MD, FASTRO, FASCO, and Sybil Green, JD, RPh, MHA, ASCO Diversity & Inclusion Officer, the virtual roundtable brought together leaders in the oncology community for an open discussion on challenges to achieving equity in precision cancer care, along with actions needed at the provider, institution, and government levels to ensure equitable access to precision medicine advances for all individuals with cancer—Every Patient. Every Day. Everywhere. Learn more or watch the recording at

Industry Related Resources

n this time of inbox overload, remember that you can utilize the NNECOS FDA Approvals page as a chronological, collated resource for the latest approval and indication information. You can also find manufacturer and drug-specific reimbursement contact information on our Regional Reimbursement Contacts page. 


     Industry Sponsored Educational Programs     FDA Approvals


Northern New England Clinical Oncology Society
P.O. Box 643
Sandown, NH 03873-0643
Telephone (603) 887-1948

This website brought to you by:

Powered by Wild Apricot Membership Software